Latest News

COVID-19 Vaccine Updates

On December 11,2020, The U.S. Food and Drug Administration issued an Emergency Use Authorization  (EAU) for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older.  The EUA allows the Pfizer-BioNTech COVID-19 to be distributed in the United States.

 

Common Side Effects:

 

The most commonly reported side effects, which typically lasts several days, were pain at the injection site, tiredness, headache, muscle pain, joint pain, and fever.  Of note, more people experienced these side effects after the second dose than after the first dose, so it is important for vaccination providers and recipients to expect that there may be some side after either dose but even more so after the second dose.

On December 18, 2020  The U.S Food and Drug Administration issued an Emergency Use Authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  The EUA allows the Moderna COVID-19 Vaccine to be distributed in the United States for use in individuals 18 years of age or older.

Common Side Effects

The most commonly reported side effects, which typically lasts several days, were pain at the injection site, tiredness, headache, muscle pain, joint pain, and fever.  Of note, more people experienced these side effects after the second dose than after the first dose, so it is important for vaccination providers and recipients to expect that there may be some side after either dose but even more so after the second dose.

Into The Light  Intl Inc. recommendation:   Take the vaccine.  The life you save might be your own!

On March 15, 2021, Into the Light International Inc.'s Founder, Sheldon Brown (pictured), received his dose of the Moderna vaccine at CVS.  The photo shown is from his experience. 

vaccinephoto_edited.jpg